What is Hereditary Hemorrhagic Telangiectasia?

Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is a genetic disorder affecting blood vessels, causing them to develop abnormally, which is identified as Telangiectasias and larger Arteriovenous malformations (AVMs) occur commonly in HHT, usually affecting the skin, nose, gastrointestinal tract, lungs, brain, and liver of the affected persons. Being fragile the vessels usually get ruptured easily, affecting the individuals with frequent bleeding, especially nose bleeding, and in some cases, significant health complications as well if AVMs occur in vital organs of their body.

What causes HHT, and what are its symptoms?

HHT is a genetically inherited condition triggered by mutations in particular genes such as ENG, ACVRL1, and SMAD4, that develops blood vessels with different symptoms but frequent and recurrent nosebleeds beginning in childhood or early adulthood remain common signs of the condition. However, small, red spots on the skin (Telangiectasias) that appear on the face, lips, tongue, and fingers are additional symptoms of HHT but headaches, seizures, breathing difficulties, or abdominal pain, also may affect the individuals if AVMs develop in organs like the brain, lungs, or liver depending on the affected organ of the body. However, according to medical experts, gastrointestinal bleeding and iron-deficiency anemia also are considered common in HHT syndromes.

How is HHT diagnosed?

Diagnosis for HHT usually requires clinical evaluations, family history, and genetic testing of the patient, which doctors conduct as common diagnostic criteria, medically known as the Curacao criteria, that include recurring nosebleeds, visible Telangiectasias, visceral AVMs, and a family history of HHT but imaging studies like MRI, CT scans, or ultrasound are also used to check AVMs in organs of the body. Moreover, genetic testing that confirms mutations associated with HHT as early diagnosis and risk assessment of family members, including screening and, most crucial test for those with a family history are conducted to track the disease of the affected person. As HHT may be asymptomatic, it requires proactive monitoring under the supervision of health experts.

What are the management and treatment options for HHT?

Treatment of HHT focuses on managing symptoms and preventing complications including common ones such as frequent nosebleeds treated with humidification, nasal sprays, laser therapy, or topical medications to reduce bleeding in the person. In cases of severe bleeding, though Embolization or surgery, to treat anemia caused due to chronic blood loss iron supplements or blood transfusions are done by health specialists. AVMs in organs like the brain or lungs usually require surgical removal, Embolization, or stereotactic Radiosurgery but above all regular monitoring specialists is very crucial, as chances of HHT being associated with different factors may not be ruled out, requiring coordinated care of different medical experts.

Are there any preventive measures for HHT?

Since HHT is a genetic condition, prevention strategies focus on managing symptoms and minimizing bleeding risks rather than preventing the disease itself. Family members of individuals with HHT are often advised to undergo genetic testing and periodic screening to detect and monitor asymptomatic AVMs. Avoiding medications that increase bleeding risk, like aspirin or non-steroidal anti-inflammatory drugs, can also help. Lifestyle adaptations, such as using a humidifier to prevent nasal dryness, may reduce the frequency of nosebleeds.

What is the prognosis for individuals with HHT?

With effective symptom management and regular monitoring, many individuals with HHT live full lives. The prognosis depends on the severity and location of AVMs. Early diagnosis and appropriate treatment are crucial, as untreated AVMs in organs such as the brain or lungs can lead to life-threatening complications like stroke or severe bleeding. Lifelong monitoring and timely intervention for organ AVMs improve overall outcomes.

How can individuals with HHT manage daily life?

Living with HHT requires regular medical follow-ups and self-care practices to minimize bleeding episodes including maintaining a well-balanced diet, avoiding tobacco, and managing stress as the routine remedial steps by a person. Most patients benefit from support groups and connecting with HHT-associated organizations for resources and guidance. Moreover, with proactive management, the individuals affected with HHT can adapt to the condition by maintaining a healthy life.

Why Tender Palm Super-Specialty Hospital for 'Hereditary Hemorrhagic Telangiectasia’?

Tender Palm Super-Specialty Hospital, led by experienced medical professionals, is recognized for its top-tier neurosurgery and vascular medicine specialists. As a leading institution in treating rare vascular disorders such as Hereditary Hemorrhagic Telangiectasia (HHT), Tender Palm stands out as the premier hospital in Gomtinagar, Lucknow, India, for neurosurgical and vascular care. Our team includes highly trained neurosurgeons and vascular specialists with expertise in managing complex conditions, including arteriovenous malformations (AVMs) associated with HHT.

Equipped with state-of-the-art medical infrastructure and the latest diagnostic technology, Tender Palm ensures patients receive advanced, high-quality treatment and compassionate care.

For expert consultation on HHT or related vascular and neurological conditions

Call us at +91-9076972161
Email at care@tenderpalm.com